Growth stocks better than value investing in 2018


The market continuous its shift in favour of growth stocks, leaving fund managers with a value-focused investment strategy struggling to keep up with the index, according to Lonsec Research.
Value investors were those that were looking for well-run businesses with solid company fundamentals that may be undervalued due to industry headwinds or temporary negative events.
According to the Lonsec study, value shares managed to outperform growth over the past ten years despite a value comeback in 2016 and the early part of 2017, however, recent performance proved the average return for value managers was in negative territory so far in 2018.
Lonsec said the behaviour of value and growth shares over different periods and the tendency for one or the other to outperform underlined the importance of diversification, not just across markets and sectors, but cross investment styles as well.
Also, despite the weaker performance of Australian shares in 2018, growth companies remained in favour and the companies operating in the consumer staples and biotechnology business were the main drivers of market returns.
At the same time, value shares which were represented by the MSCI Australia Value Index were weighed down by poor performance from financials and telecommunications shares, including the major banks that were under pressure from the Royal Commission into Financial Services.
Recommended for you
Australian equity ETFs attracted record inflows of $3.2 billion in 1Q25, while heightened volatility led to a decline in flows for global equity ETFs, according to Vanguard.
The failure of a clinical trial by biotech firm Opthea has caused shares in its backer Regal Partners to decline 52 per cent year-to-date and hit its funds under management, quarterly flows show.
GQG Partners has revealed its quarterly flows for the first three months of 2025 were up 5.8 per cent, after a difficult final quarter of 2024 as a result of institutional redemptions.
Global asset manager Janus Henderson has signed a strategic partnership with life insurer Guardian Life, which will commit US$400 million to accelerate the firm’s fixed income development plans.